HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alessandro Allegra Selected Research

artemisin

1/2021Drug Repositioning for the Treatment of Hematologic Disease: Limits, Challenges and Future Perspectives.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alessandro Allegra Research Topics

Disease

50Neoplasms (Cancer)
03/2022 - 12/2009
41Multiple Myeloma
05/2022 - 08/2008
11Hematologic Neoplasms (Hematological Malignancy)
01/2022 - 11/2016
8Osteonecrosis (Kienbock's Disease)
01/2019 - 08/2008
7Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
05/2021 - 03/2007
6Lymphoma (Lymphomas)
06/2021 - 10/2010
6B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2020 - 01/2012
6Bisphosphonate-Associated Osteonecrosis of the Jaw
01/2020 - 09/2007
5Hematologic Diseases (Blood Diseases)
01/2022 - 01/2017
5Leukemia
06/2021 - 12/2009
5Inflammation (Inflammations)
05/2021 - 01/2017
5Infections
01/2021 - 06/2010
5Polycythemia Vera
10/2020 - 01/2011
4Osteoporosis
08/2021 - 03/2015
4Carcinogenesis
07/2021 - 10/2019
4Pruritus (Itching)
06/2021 - 07/2012
4Paraproteinemias (Monoclonal Gammopathy)
05/2021 - 10/2012
4BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2021 - 01/2012
4Essential Thrombocythemia
03/2013 - 01/2011
3Hypersensitivity (Allergy)
03/2022 - 03/2015
3Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2022 - 11/2016
2African Trypanosomiasis (Nagana)
08/2022 - 05/2020
2Pathologic Processes
03/2022 - 12/2017
2Peripheral Nervous System Diseases (PNS Diseases)
01/2022 - 01/2018
2Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune)
10/2021 - 09/2010
2Myelodysplastic Syndromes (Myelodysplastic Syndrome)
05/2021 - 06/2010
2Monoclonal Gammopathy of Undetermined Significance
02/2021 - 06/2019
2Hypertension (High Blood Pressure)
01/2021 - 01/2007
2Bone Resorption
01/2020 - 07/2018
2Stevens-Johnson Syndrome (Lyell's Syndrome)
06/2013 - 03/2012
1Myositis (Idiopathic Inflammatory Myopathies)
06/2022
1Muscular Diseases (Myopathy)
06/2022
1Disease Progression
05/2022
1Respiratory Tract Diseases (Respiratory Tract Disease)
03/2022
1Virus Diseases (Viral Diseases)
03/2022
1Painful Neuropathy
01/2022
1Systemic Scleroderma (Systemic Sclerosis)
01/2022

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
03/2022 - 07/2010
11MicroRNAs (MicroRNA)IBA
03/2022 - 12/2012
9Pharmaceutical PreparationsIBA
02/2022 - 09/2011
9CytokinesIBA
06/2021 - 06/2015
8Diphosphonates (Bisphosphonates)IBA
01/2021 - 08/2008
6Biomarkers (Surrogate Marker)IBA
03/2022 - 10/2012
6Interleukin-33IBA
03/2022 - 03/2013
5Immunoglobulins (Immunoglobulin)IBA
06/2022 - 05/2011
5Bortezomib (Velcade)FDA Link
01/2022 - 06/2013
5Biological ProductsIBA
02/2020 - 06/2010
4Proteasome InhibitorsIBA
02/2022 - 01/2014
4Advanced Glycation End ProductsIBA
03/2019 - 01/2012
4Lenalidomide (CC 5013)FDA Link
06/2013 - 03/2012
4Interleukin-22 (IL-22)IBA
01/2013 - 05/2011
3Lipocalin-2IBA
03/2022 - 01/2011
3CurcuminIBA
01/2021 - 01/2017
3Monoclonal AntibodiesIBA
12/2020 - 06/2013
3AntagomirsIBA
11/2020 - 03/2020
3AntigensIBA
10/2020 - 11/2016
3carfilzomibIBA
06/2020 - 01/2018
3Imatinib Mesylate (Gleevec)FDA Link
06/2015 - 03/2007
3Advanced Oxidation Protein Products (AOPP)IBA
11/2012 - 01/2012
2rhodesainIBA
08/2022 - 05/2020
2Interleukin-10 (Interleukin 10)IBA
03/2022 - 07/2012
2CannabinoidsIBA
11/2021 - 06/2021
2Dexamethasone (Maxidex)FDA LinkGeneric
11/2021 - 12/2017
2Therapeutic UsesIBA
10/2021 - 04/2021
2AutoantibodiesIBA
10/2021 - 09/2010
2AlarminsIBA
08/2021 - 10/2019
2SteroidsIBA
05/2021 - 03/2015
2Hormones (Hormone)IBA
05/2021 - 01/2009
2Tyrosine Kinase InhibitorsIBA
12/2020 - 06/2015
2Immune Checkpoint InhibitorsIBA
10/2020 - 06/2020
2GlucocorticoidsIBA
07/2020 - 05/2015
2Thalidomide (Thalomid)FDA Link
06/2020 - 06/2013
2Clodronic Acid (Clodronate)IBA
10/2017 - 03/2015
2Rituximab (Mabthera)FDA Link
01/2017 - 06/2014
2InterleukinsIBA
06/2015 - 07/2012
2Interleukin-23 (Interleukin 23)IBA
07/2012 - 05/2011
2Interleukin-17 (Interleukin 17)IBA
05/2011 - 08/2008
2ErythropoietinFDA Link
01/2009 - 12/2005
1Cysteine Proteases (Cysteine Protease)IBA
08/2022
1Intravenous Immunoglobulins (IVIG)FDA Link
06/2022
1Histone MethyltransferasesIBA
05/2022
1Lysine (L-Lysine)FDA Link
05/2022
1Histone Acetyltransferases (Histone Acetyltransferase)IBA
05/2022
1Circular RNAIBA
03/2022
1Transcription Factors (Transcription Factor)IBA
03/2022
1Chemokine CCL1IBA
03/2022
1ChemokinesIBA
03/2022
1Immunoglobulin G (IgG)IBA
03/2022
1Immunoglobulin E (IgE)IBA
03/2022
1AntibodiesIBA
03/2022
1AllergensIBA
03/2022
1Immunologic Factors (Immunomodulators)IBA
02/2022
1Trinitrotoluene (TNT)IBA
01/2022

Therapy/Procedure

33Therapeutics
03/2022 - 12/2009
10Drug Therapy (Chemotherapy)
10/2021 - 12/2009
5Immunotherapy
01/2022 - 11/2015
4Radiotherapy
01/2022 - 01/2013
2Photochemotherapy (Photodynamic Therapy)
12/2020 - 05/2020
1Immunomodulation
03/2022
1Autologous Transplantation
02/2022